Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Human clinical trial of plasmapheresis effects on biomarkers of aging (efficacy and safety trial)

P. Borsky, D. Holmannova, H. Parova, S. Horvath, P. Sramek, RT. Brooke, M. Milciute, J. Gordevicius, Z. Fiala, C. Andrys, J. Kremlacek, V. Rehacek, I. Baranova, N. Matyasovska, L. Borska

. 2025 ; 15 (1) : 21059. [pub] 20250701

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25022513

Plasmapheresis is a medical procedure that separates plasma from blood cells, potentially removing pro-aging factors from circulation. Some studies suggest it may have rejuvenating effects by altering biomarkers of aging, but evidence on its impact on epigenetic aging in humans is limited. This study aimed to assess whether plasmapheresis without volume replacement with young plasma or albumin affects epigenetic age and other biomarkers in healthy adults. An automatic plasma collection system, the Haemonetics PCS2, was used for plasmapheresis. Healthy blood donors were divided into two groups using stratified randomization in a cross-over study with subjects undergoing either 8 plasmaphereses (8 pp) or 4 plasmaphereses (4 pp) for an 18-week period, with a minimum interval between plasmaphereses of 2 weeks (14 days). Samples were tested for biochemical, hematological analyses and epigenetic clocks. We documented the alteration in serum minerals, decreased serum lipids, mainly total cholesterol, non-HDL, triglycerides, apolipoprotein A levels, total proteins and albumin. Among hematologic parameters, we found an increase in Red Cell Distribution Width (RDW) and Mean Corpuscular Hemoglobin Concentration (MCHC). No significant epigenetic rejuvenation was observed based on epigenetic clock measurements. Instead, plasmapheresis was associated with increases in DNAmGrimAge, the Hannum clock, and the Dunedin Pace of Aging. Plasmapheresis can rapidly change the levels of pro-inflammatory and other pro-aging molecules in the circulation. However, the selected protocol has not provided conclusive data supporting benefits. Based on epigenetic clock parameters, it may accelerate epigenetic aging. More research into the long-term safety of this specific protocol is needed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25022513
003      
CZ-PrNML
005      
20251023080343.0
007      
ta
008      
251014s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-025-05396-0 $2 doi
035    __
$a (PubMed)40592961
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Borsky, Pavel $u Department of Preventive Medicine, Institute Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 50038, Hradec Kralove, Czech Republic. borskyp@lfhk.cuni.cz
245    10
$a Human clinical trial of plasmapheresis effects on biomarkers of aging (efficacy and safety trial) / $c P. Borsky, D. Holmannova, H. Parova, S. Horvath, P. Sramek, RT. Brooke, M. Milciute, J. Gordevicius, Z. Fiala, C. Andrys, J. Kremlacek, V. Rehacek, I. Baranova, N. Matyasovska, L. Borska
520    9_
$a Plasmapheresis is a medical procedure that separates plasma from blood cells, potentially removing pro-aging factors from circulation. Some studies suggest it may have rejuvenating effects by altering biomarkers of aging, but evidence on its impact on epigenetic aging in humans is limited. This study aimed to assess whether plasmapheresis without volume replacement with young plasma or albumin affects epigenetic age and other biomarkers in healthy adults. An automatic plasma collection system, the Haemonetics PCS2, was used for plasmapheresis. Healthy blood donors were divided into two groups using stratified randomization in a cross-over study with subjects undergoing either 8 plasmaphereses (8 pp) or 4 plasmaphereses (4 pp) for an 18-week period, with a minimum interval between plasmaphereses of 2 weeks (14 days). Samples were tested for biochemical, hematological analyses and epigenetic clocks. We documented the alteration in serum minerals, decreased serum lipids, mainly total cholesterol, non-HDL, triglycerides, apolipoprotein A levels, total proteins and albumin. Among hematologic parameters, we found an increase in Red Cell Distribution Width (RDW) and Mean Corpuscular Hemoglobin Concentration (MCHC). No significant epigenetic rejuvenation was observed based on epigenetic clock measurements. Instead, plasmapheresis was associated with increases in DNAmGrimAge, the Hannum clock, and the Dunedin Pace of Aging. Plasmapheresis can rapidly change the levels of pro-inflammatory and other pro-aging molecules in the circulation. However, the selected protocol has not provided conclusive data supporting benefits. Based on epigenetic clock parameters, it may accelerate epigenetic aging. More research into the long-term safety of this specific protocol is needed.
650    _2
$a lidé $7 D006801
650    12
$a biologické markery $x krev $7 D015415
650    12
$a plazmaferéza $x metody $x škodlivé účinky $7 D010956
650    12
$a stárnutí $x krev $x genetika $7 D000375
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a klinické křížové studie $7 D018592
650    _2
$a epigeneze genetická $7 D044127
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Holmannova, Drahomira $u Department of Preventive Medicine, Institute Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 50038, Hradec Kralove, Czech Republic
700    1_
$a Parova, Helena $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Horvath, Steve $u Epigenetic Clock Development Foundation, Torrance, CA, USA $u Altos Labs UK Limited, Cambridge, UK
700    1_
$a Sramek, Petr $u HealthyLongevity.Clinic Inc., Boca Raton, FL, USA
700    1_
$a Brooke, Robert T $u Epigenetic Clock Development Foundation, Torrance, CA, USA
700    1_
$a Milciute, Milda $u Epigenetic Clock Development Foundation, Torrance, CA, USA
700    1_
$a Gordevicius, Juozas $u Epigenetic Clock Development Foundation, Torrance, CA, USA
700    1_
$a Fiala, Zdenek $u Department of Preventive Medicine, Institute Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 50038, Hradec Kralove, Czech Republic
700    1_
$a Andrys, Ctirad $u Department of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Kremlacek, Jan $u Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Rehacek, Vit $u Transfusion Department, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Baranova, Ivana $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Matyasovska, Natalia $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Borska, Lenka $u Department of Preventive Medicine, Institute Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 50038, Hradec Kralove, Czech Republic
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 15, č. 1 (2025), s. 21059
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40592961 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023080348 $b ABA008
999    __
$a ok $b bmc $g 2417334 $s 1260676
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 15 $c 1 $d 21059 $e 20250701 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace